ARVN
ARVINAS, INC.
NASDAQ · Healthcare · Biotechnology · US
$7.42
+4.65%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -0.16x
- Debt / assets
- 0.01x
- Debt / EBITDA
- -0.34x
- Net debt / EBITDA
- 3.71x
Liquidity & coverage
- Current ratio
- 8.39x
- Quick ratio
- 8.39x
- Cash ratio
- 7.98x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $517.6M
Cash & dividend
- FCF / debt
- -21.59x
- Cash flow / debt
- -21.39x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026